Cannonau Corp.
CNNCOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$48275
P/E Ratio—
52W High$0.0401
52W Low$0.0001
Cannonau Corp. (CNNC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CNNC · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2024Report Date: Apr 12, 2024EPS Actual
$0.15
Revenue
—
Fiscal Period
Q2 FY2024
FY ends December
Report Date
Apr 12, 2024
After Market Close
CNNC reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.20
Rev. $4.26B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.20
Rev. Est.$4.26B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2025 | Jun 4, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 30, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Feb 28, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Nov 22, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 21, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | Jun 5, 2024 | — | — | — | — | — | — |
| — Q2 FY2024 | Apr 12, 2024 | — | $0.15 | — | — | — | — |
| — Q4 FY2023 | Nov 13, 2023 | — | -$0.00 | — | — | — | — |
Q2 FY2025
Jun 4, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 30, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 22, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 21, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Jun 5, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Apr 12, 2024
EPS Actual
$0.15
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 13, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.57 | $1.57 | $1.57 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2024 | Apr 12, 2024 | — | $0.01 | $0.01 | +9.09% |
| — Q4 FY2023 | Nov 13, 2023 | — | $0.01 | $0.01 | +27.27% |
| — Q3 FY2023 | Aug 21, 2023 | — | $0.02 | $0.02 | +0.00% |
| — Q2 FY2023 | May 12, 2023 | — | $0.02 | $0.02 | +23.53% |
| — Q1 FY2023 | Mar 3, 2023 | — | $0.02 | $0.02 | +7.71% |
| — Q4 FY2022 | Nov 14, 2022 | — | $0.02 | $0.02 | +4.44% |
Q2 FY2024+9.09%
Report Date
Apr 12, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2023+27.27%
Report Date
Nov 13, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2023+0.00%
Report Date
Aug 21, 2023
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q2 FY2023+23.53%
Report Date
May 12, 2023
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q1 FY2023+7.71%
Report Date
Mar 3, 2023
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q4 FY2022+4.44%
Report Date
Nov 14, 2022
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Beat Rate0 / 6 quarters
Largest Move+27.27% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CNNC ends December
Cannonau Corp. (CNNC) most recently reported earnings on April 12, 2024 for Q2 FY2024, posting EPS of $0.15 (in line with the analyst consensus of —). The next CNNC earnings date is expected around September 1, 2026.
Each quarter, investors track CNNC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CNNC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CNNC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CNNC earnings · 4 questionsCannonau Corp.'s next earnings report is expected around September 1, 2026. CNNC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CNNC historically reports after market close (AMC).
CNNC earnings datewhen is CNNC earningsCNNC next earnings datewhen does CNNC report earningsCNNC earnings calendar
▸ Source: FMP · Cannonau Corp. SEC filings · US GAAP · Cannonau Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026